Total:2
-
2022-02-20 18:42
Cov Pars begins clinical trial on adolescents
TEHRAN – The domestically-made Cov Pars Razi vaccine has received the license for a clinical trial on adolescents, Mehr news agency reported on Sunday.
-
2021-11-14 19:00
Cov Pars causes 9-12 months immunity to COVID-19
TEHRAN – Studies show that Cov Pars vaccine, developed by the Razi Vaccine and Serum Research Institute of Iran, makes immunity for 9-12 months against the coronavirus, Reza Bani-Hashemi, the director for research and development at the institute, said on Sunday.